Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients

Transplantation

Volumn 63, Issue 11, 1997, Pages 1634-1639

  Morales, J M ^a   Pascual Capdevila, J ^b   Campistol, J M ^b   Fernandez Zatarain, G ^a   Munoz M A ^a   Andres, A ^a   Praga, M ^a   Martinez, M A ^a   Usera, G ^a   Fuertes, A ^a   Oppenheimer, F ^b   Artal, P ^a   Darnell, A ^b   Rodicio, J L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; CREATININE; CRYOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; DETERIORATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BIOPSY; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; PROTEINURIA; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030979330     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706150-00017     Document Type: Article

References (29)

1. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-surviving renal allografts. Kidney Int 1985; 28: 839.
2. Pereira BJG. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens 1993; 2: 912.
3. Pereira BJG, Milford EL, Kirkman RL, et al. Prevalence of HCV RNA in hepatitis C antibody positive cadaver organ donors and their recipients. N Engl J Med 1992; 327: 910.
4. Morales JM, Muñoz MA, Castellano G, et al. Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up. Transplant Proc 1993; 25: 1450.
5. Rodicio JL, Morales JM. Liver disease in renal transplant patients. In: Massry SG, Glassock RJ, eds. Textbook of nephrology, Vol. 2. Baltimore: Williams & Wilkins, 1995: 1684.
6. Roth D. Hepatitis C virus: the nephrologist's view. Am J Kidney Dis 1995; 25: 3.
7. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663.
8. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465.
9. Johnson RJ, Willson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994; 46: 1255.
10. Okada K, Takishita Y, Shimomura H, et al. Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis. Clin Nephrol 1996; 45: 71.
11. Burstein DM, Rodby RA. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 1993; 4: 1288.
12. Davda R, Peterson J, Weiner R, Croker B, Lau JY. Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993; 22: 452.
13. Roth D, Cirocco R, Zucker K, et al. "De novo" membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995; 59: 1.676.
14. Gallay BJ, Alpers CHE, Davies CL, Schultz MF, Johnson RJ. Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995; 26: 662.
15. Cameron JS. Glomerulonephritis in renal transplantation. Transplantation 1982; 34: 237.
16. Eknoyan E. Glomerular abnormalities in liver disease. In: Epstein M, ed. The kidney in liver disease, 3rd ed. New York: Elsevier Biomedical, 1989: 155.
17. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991; 59: 319.
18. Stehman-Breen C, Alpers CE, Cpiser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995; 44: 141.
19. Takishita Y, Ishikawa S, Okada K. Two cases of membranous glomerulonephritis associated with hepatitis C virus. Nippon Jinzo Gakkai Shi 1994; 36: 1203.
20. Schwartz A, Krause PH, Offerman G, Keller G. Impact of "de novo" glomerulonephritis on the clinical course after kidney transplantation. Transplantation 1994; 58: 650.
21. Castelao A, Campistol JM, Grinyo JM, et al. HLA-DR5 and allograft membranous glomerulonephritis: frequent association. Transplant Proc (in press).
22. Berger BE, Vicenti F, Biava C. "De novo" and recurrent glomerulonephritis following kidney transplantation. Transplantation 1983; 35: 315.
23. Truong I, Gelfand J, D'Agati V. "De novo" membranous glomerulopathy in renal allografts: a report often cases and review of the literature. Am J Kidney Dis 1989; 14: 131.
24. Johnston PA, Goode NP, Aparicio SR, Davison AM. Membranous allograft nephropathy: remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids. Transplantation 1993; 55: 214.
25. Appel GB. Immune-complex glomerulonephritis-deposits plus interest [Editorial]. N Engl J Med 1993; 328: 505.
26. Josephson MA, Spargo B, Hollandsworth D, Thistlethwaite JR. The recurrence of recurrent membranous glomerulonephritis in a renal transplant recipient: case report and literature review. Am J Kidney Dis 1994; 24: 873.
27. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects amino-transferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196.
28. Morales JM, Campistol JM, Castellano G, et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995; 47: 236.
29. Lok ASF, Chien D, Choo QL, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 1993; 18: 497.